New drug combo aims to shrink spleen in myelofibrosis patients who Can't take standard therapy
Disease control
Not yet recruiting
This study tests a combination of two drugs, pacritinib and selinexor, in people with myelofibrosis who have low red blood cell and platelet counts and have not yet received JAK inhibitor therapy. The goal is to see if this combination can safely shrink an enlarged spleen and imp…
Phase: PHASE2 • Sponsor: John Mascarenhas • Aim: Disease control
Last updated Apr 29, 2026 07:13 UTC